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Genitourinary Tuberculosis: a Profile of 55 in-Patients 
N.P. Buchholz,R. Haque  ( Departments of Surgery, The Aga Khan University, Karachi. )  
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Abstract  
Objective: To outline the pattern and trends in major cases of genito-urinary tuberculosis 
(GUTB) which require hospital treatment. 
Method: We retrospectively reviewed 55 patients with proven GUTB who were treated as in-
patients in a major referral hospital in Pakistan. 
Results: The male/female ratio was 3:1. Prevailing symptoms were lower urinary tract 
symptoms, flank pain, gross hematuria and fever. A urine culture was positive for tuberculosis 
(TB) in 57%, bladder biopsies in 54%. For renal TB, intravenous urogram (IVU) and ultrasound 
were suggestive in about 50% of cases. Ultrasound was very helpful in the diagnosis of testicular 
TB. Patients underwent surgery in 36% of cases. In contrast to the general trend reported 
worldwide, surgery was mainly ablative rather than re-constructive. Patient compliance in 
clinical follow-up and drug therapy was poor. 
Conclusion: Surgery for GUTB in Pakistan is still mainly ablative, probably due to a high 
number of complicated and progressed cases, To date, therapy of GUTB is mainly based on anti-
tuberculosis chemotherapy (AU). However, huge efforts will be required to improve patient 
compliance without which every therapeutic approach will remain futile JPMA 50:265, 2000). 
Introduction  
Tuberculosis (TB) still causes a great deal of ill health in the population of most low income 
countries. In Pakistan, there are 300,000 new cases every year as per WHO estimation. Three 
quarters of patients are concentrated in the productive age group of between 15 and 59 years 
which means an enormous social and economic burden1. Thirty-three percent of all TB cases are 
extrapulmonary (EPTB). Although patients with EPTB hardly ever spread the disease1, this form 
of the disease is a major health problem due to its destructive nature2. Genitourinary tuberculosis 
(GUTB) is the most frequent type of extrapulmonary TB in 40.9 to 54%3,4, After the introduction 
of anti-tuberculosis chemotherapy (ATT), the incidence of GUTB has remained stable for some 
time3 and is now on the rise again in most countries, partly due to the development of drug-
resistance and to its frequent association with AIDS5. Diagnosis has become more sophisticated 
using serological tests and polymerase chain reaction (PCR)6. The incidence of GUTB is now 
estimated at 3 new cases per million population per year (WHO, 1981). 
Yet, to our knowledge there are only a few studies dealing with GUTB. One series reports of 
more than 1000 cases, however during a period of 34 years which includes entirely different and 
incomparable treatment approaches7. There are two more reports of series of8l 4 and 12 3 cases, 
respectively. These studies have been conducted in Europe. There are few studies comprising a 
representative study population from so called low income countries 8,9. Therefore, we have 
reviewed 55 of our cases and like to share our findings here. 
Material and Methods  
In a retrospective study, we reviewed the medical records of 189 patients who had been treated 
as in-patients for genitourinary tuberculosis (GUTB) at the Aga Khan University Hospital from 
1985 to 1997. Since only in-patients are coded for diagnosis in our hospital to date, we had to 
limit our analysis to in-patients. Also, only such patients were included who had a GUTB proven 
either by at least one urine culture positive for Mycobacterium tuberculosis, or a 
histopathological confirmation of caseating necrotic lesions in a biopsy or surgery specimen. The 
medical records of 55 such qualified patients were analysed with regard to age, sex, concomitant 
diseases, medical history, symptoms, diagnosis, treatment and follow-up. The remaining 134 
patients had been treated on strong clinical suspicion alone and were, therefore, excluded from 
the study. Our results were then compared with those of other series reported in the international 
literature. 
Treatment of GUTB patients in our institution followed WHO categorisation guidelines (WHO, 
1996), rcommending for most patients a 4-drug regimen (isoniazid, ethambutol, rifampicin and 
pyrazinamide or, alternatively, in few selected cases streptomycin) for an initial phase of 2 
months and a 2-drug regimen (usually comprising isoniazid and rifampicin) for a further 6 
months. If indicated, patients were tested for multi-drug-resistance. A databank was set up by 
means of Microsoft Excel® software. 
Results  
The mean age of the 55 patients included in this study was 39.9±17.1 years (7-81 years). There 
were 41 (74%) males. Fifty-one (93%) patients were in category 1 (active pulmonary TB or 
extra-pulmonary TB with serious illness), 3 (5.4%) in category II (re-treatments) and 1(1.8%) in 
category Ill (extra-pulmonary TB without serious illness and children under 15 years of age). 
The prevailing symptoms were of the lower urinary tract, flank pain and fever (Table 1). 
 
None had a history of previous pulmonary tuberculosis (PTB). However, 6 patients (11%) had a 
history of extrapulmonary tuberculosis (EPTB) which dated back 4 years on average. Five had 
had GUTB and one a pleural affection. The chest X-ray suggested previous PTB in 14% of our 
cases. Concomitantly, there was diabetes mellitus in 33% of our patients, but no malignancy, or 
long-term cortisone therapy and no AIDS. 
As to laboratory findings, 36% of patients had microhematuria in their urine, 56% had a 
leucocyturia and 19% had a sterile pyuria. In 44 patients, one or more urine cultures were taken. 
They were positive for Mycobacterium tuberculosis in 25 (57%). A concomitant urinary tract 
infection with organisms other than mycobacteria was present in 9 patients (20%). Ziehl-Neelsen 
stained urine smear was positive for Mycobacterium tuberculosis in only one case. In two 
patients, mycobacteria could be cultured in abscess fluid (Table 2).  
 
Of a total of 26 bladder biopsies, 14 (54%) showed evidence of tuberculosis. The results of 
diagnostic imaging and cystoscopies have been listed in Table 3. 
 
 
Surgery was performed on 20 patients (36%). Most of the operations were ablative surgery, few 
re-constructive procedures (Table 4).  
 Cystoscopies and bladder biopsies have not been listed under surgical procedures. 
Histopathology on surgical specimen showed evidence of tuberculosis in 8 out of 9 removed 
kidneys (89%) where these results were available and in 5 out of 5 removed testicles (100%). 
Anti-tuberculosis therapy (ATT) was recordedly started in 38 patients (69%). Sixteen patients 
(29%) were tested for multiple drug resistance. One patient developed a resistance against 
rifampicin (6.2%) and each two patients (12.5%) against isoniazid and strepromycin, 
respectively. Thirty-five patients (64%) were followed up after their initial visit. The average 
clinical follow-up in our out-patient clinic was 15.1 months (1-52 months). Patients had an 
average of 4.9 visits (1-21) during that time. Thirty-seven percent of patients visited our clinic 
after 8 months (which corresponds to the recommended duration of ATT) and 43% of patients 
recordedly completed the 8 months course of ATT. Symptoms ceased in half of the patients after 
3 months and in >60% after 4 months. After 10 months, patients did no more complain about any 
previous presenting symptoms. The numbers of fo l towed-up patients, patients under ATT and 
patients with persistent symptoms associated with GUTB are depicted in Figure. 
  
Urine cultures after the onset of ATT remained negative for M. tuberculosis in all cases. There 
were few positive bladder biopsies within the first 3 months of follow-up, however, none after 
that time. 
Discussion  
Tuberculosis (TB) in general and genitourinary tuberculosis (GUTB) in particular. can be 
defined as an infectious, systemic, chronic and granulomatous disease1. These characteristics 
imply a lot of well known clinical problems. But apart from clinical problems, TB has an 
enormous social and financial impact upon the population in Western, as well as in so called low 
income countries1,2. As all forms of TB, GUTB, too, affects mostly people in the productive age 
between 15 and 59 years 1,3,4,7,10, This is also true for our patient population as shown by our 
mean age of 39.9±17.1 years. In a country like Pakistan, frequently many people within a family 
depend on one limited income. In case that the earner falls ill, there is no ‘social net’ to 
compensate for the loss of income, no health insurance to cover the costs of treatment and no 
government welfare office for those people to turn to. The clinical burden of GUTB may hence 
turn into a social catastrophe. 
It seems, therefore, reasonable to re-evaluate the profile of GUTB as it presents today in a major 
urology unit in Pakistan. Although it is recommended and commonly accepted that patients with 
the clinical picture of a likely TB who, in addition. did not clinically respond to two weeks of 
antibiotic therapy, are classified and treated as TB 1, we included in this study only in-patients 
with a microbiologially or histopathologically proven GUTB. There were 55 such patients out of 
189 who had been diagnosed and treated as in-patients for GUTB on grounds of strong clinical 
suspicion. There was, however, a limitation in our choice of patients insofar as only in-patients 
are coded for diagnosis in this hospital, There is a number of patients with GUTB who had never 
been admitted and were, therefore, unidentifiable. Therefore, the number of 55 patients with 
proven GUTB does admittedly not reflect the true incidence of the disease in this country and in 
our hospital. However, it does reflect the picture of all the shades of the disease in a more 
progressed state. There is a male predominance in GUTB4,7 which was also confirmed in our 
study with a male/female ratio of 3:1. 
None of our patients reported a history of previous pulmonary TB (PTB) and chest X-rays were 
suggestive of previous PTB in 14%. This is in contrast to other studies which reported a history 
of PTB in 16 to 30% of cases3,4,7 and TB positive chest X-rays in as much as 58%4. The lack of a 
history of previous PTB in our patients may be explained by the lack of screening and health 
care in our population, possibly resulting in a previous PTB going unnoticed and undiagnosed. 
It is well known, that GUTB occurs more frequently in persons who display concomitant 
conditions such as malignancy, diabetes mellitus, long-term cortisone therapy, malnutrition 11,12 
and more recently, AIDS5. Of those, only diabetes mellitus was associated with tuberculosis in 
our study population. Thirty-three percent of our patients had indeed, diabetes mellitus. This can 
be explained by the fact that there is a comparatively higher incidence of diabetes mellitus in 
Pakistan than in other countries13 which may have genetical and nutritional reasons but certainly 
puts more people to the risk of concomitant infections such as tuberculosis. 
In general, GUTB is characterised by the occurrence of local symptoms rather than constitutional 
ones4. Lower urinary tract symptoms have been reported as the most frequent symptoms in 
GUTB4 4,10. Also, due to the fact that renal TB accounts for 50% of cases of GUTB, flank pain is 
a frequent symptom in GUTB4. Gross hematuria in 1014 to 36%4 of cases frequently is the 
symptom that finally urges the patient to see a doctor. Our findings compare very well with these 
reports with one exception, however, fever occurred in 36% of our patients. This is most likely 
due to a high number of complicated and progressed cases displaying associated complications 
as we see them frequently. Again, this results from a lack of health education and infrastructure 
in this country which causes a delay in reporting to a primary health carer who then refers them 
to us as a complicated case. 
The diagnosis of GUTB is based on a combination of clinical signs and ideally on a positive 
Ziehl-Neelsen stained smear or urine culture, or a positive biopsy. Whereas there was only one 
positive urine smear, urinary culture showed evidence of GUTB in 57%. In two cases, the 
diagnosis was confirmed by culture of abscess fluid. 
Bladder biopsies were confirmative for GUTB in 54%. In other series, urine cultures have been 
reported to be positive in 54 to 73% of GUTB cases10,15 endoscopic biopsies in 15%10. Our 
findings confirm that the sensitivity for urine cultures lies somewhere around 50%. However, 
they suggest that also bladder biopsies have a similar sensitivity range and are, therefore, a useful 
diagnostic tool in the evaluation of GUTB. 
Other urinary parameters such as microhernaturia or leucocyturia may support the diagnosis4,10. 
They occur quite frequently. However, the often cited classical sign of sterile pyuria was present 
in only 19% of our cases. 
Diagnostic imaging and endoscopy can only give indirect clues for the diagnosis of GUTB. We 
cannot confirm the high incidence of kidney abnormalities in GUTB as shown by IVP of 95%4 
However, about half of our patients showed renal alterations in IVP and sonography. Ultrasound 
was also very accurate in the diagnosis of testicular TB. The visualisation of a tuberculous 
bladder gave the right clues in as much as 57% which, together with the number of positive 
bladder biopsies, makes it a valuable diagnostic tool for GUTB of the bladder. 
As to the treatment, 35 patients (64%) were managed conservatively and 20 (36%) underwent 
surgical procedures. Since the arrival of ATT, there was a shift from ablative to reconstructive 
surgery for the treatment of GUTB16. Compared with the literature7,17 we performed, however, 
clearly more ablative surgery (80% versus 48/58%) and few reconstructive procedures. This may 
be caused, as mentioned earlier, by the referral of complicated cases to us as a tertiary referral 
centre which necessitated radical surgery as ultimate means. Similarly, given the patient and 
health system structure in low income countries, we see quite a lot of progressed cases with 
extended tissue destruction which also necessitate ablative surgery rather than reconstruction. 
The introduction of ATT has reduced the mortality of GUTB from formerly 58~85%18 to less 
than 5%19 However, there is no unanimosity with regard to ATT for GUTB. More than 15 
possible drug combinations have been described20 and recommendations for the duration of 
treatment vary from 4 to 12 months4,7. The effectiveness of ATT is also somewhat questionable, 
since in 52% of surgical specimens, a florid TB was found after previous ATT for 9 (!) months17. 
For our patients, we followed the WHO guidelines which to date recommend a 4-drug therapy 
for an initial phase of 2 months, followed by a 2-drug regimen for a further 6 months (WHO, 
1996). Usually, rifampicin and isoniazid are give in both phases. However, especially in a 
infrastructurally and educationally weak country like ours, there is a huge problem with patient 
compliance. Long-term follow-up is only followed by a minority of patients and only 43% of 
patients under ATT completed the full 8 months course. Patient guidance, motivation and 
education clearly are areas of emphasis in the future. 
This will also have an impact on the sharp rise of ATT-resistant TB following incomplete or 
incorrect drug regimens. There are to date no data available with regard to the multi-drug-
resistance in our country, however, our findings may give valuable clues to that regard; drug 
resistance was found in 6.2% of patients for rifampicin and in 12.5% for either isoniazid and 
streptomycin. And this in spite of the fact that only 5.4% of our patients were re-¬treatment 
cases. 
First steps have been taken in our institution to improve patient compliance and overall 
performance of everyone involved in tuberculosis treatment with the introduction of a TB 
surveillance program which is, however, still in its early stages. 
In conclusion, GUTB is still a prevalent problem with an enormous clinical and social impact. 
The latter is aggravated in low income countries due to the lack of compensatory mechanisms. 
The clinical picture compares with that reported in Western series. In summary, surgery for 
GUTB in Pakistan is still often ablative due to the high number of complicated and progressed 
cases. However, there are to date many centers in Pakistan using re¬constructive procedures 
such as bladder augmentation, cystoplasty, pyeloplasty and ureteroplasty in an effort to maintain 
the organs and to ensure a better quality of life for the patient. For diagnosis of bladder TB, we 
found cystoscopy and bladder biopsy a valuable tool. Therapy of GUTB is mainly based on 
ATT. However, huge efforts will be required in the future to markedly improve patient 
compliance without which even the best therapeutic approach will remain futile. 
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